je.st
news
Medivir Ab: Phase II Cosmos Study Results Published In Lancet On World Hepatitis Day
2014-07-28 19:39:48| Appliances - Topix.net
The phase II COSMOS study evaluated the interferon-free combination of simeprevir and sofosbuvir in treatment-naive and prior null-responder patients with all stages of liver fibrosis, including cirrhosis.
Tags: day
results
world
study
Category:Consumer Goods and Services